Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Annie Brion"'
Autor:
Caroline Algrin, Louis Pérol, Elise Chapiro, Lucile Baseggio, Karim Maloum, Catherine Settegrana, Jean-François Lesesve, Justine Siavellis, Alain Delmer, Anne-Sophie Michallet, Emmanuelle Ferrant, Pierre Feugier, Cécile Tomowiak, Annie Brion, David Ghez, Luc-Matthieu Fornecker, Sarah Ivanoff, Stéphanie Struski, Laurent Sutton, Isabelle Radford-Weiss, Virginie Eclache, Christine Lefebvre, Véronique Leblond, Florence Nguyen-Khac, Damien Roos-Weil
Publikováno v:
Haematologica, Vol 108, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/b2abff8bb5904fc89c971c8ade3b86be
Autor:
Ana Berceanu, Alix Pierron, Catherine Chirouze, Jean Fontan, F. Bozon, Anne-Sophie Brunel, Erick Deconinck, Annie Brion
Publikováno v:
Vaccine. 39:7036-7043
Introduction Immunocompromised patients are at high-risk for severe influenza and invasive pneumococcal diseases (IPD). Despite the French Public Health Council (FPHC) and the 7th European Conference on Infections in Leukaemia (ECIL7) recommendations
Autor:
Julien, Labreuche, Deborah, Assouan, Eric, Durot, Cecile, Tomowiak, Damien, Roos-Weil, Elise, Toussaint, Fontanet, Bijou, Richard, Lemal, Annie, Brion, Kamel, Laribi, Loic, Ysebaert, Alain, Duhamel, Pierre, Morel
Publikováno v:
Hematological oncology. 40(3)
In symptomatic Waldenström macroglobulinemia (sWM) patients, prognosis is assessed with the international prognostic scoring system (IPSSWM). In follicular lymphoma and other B-cell and T-cell lymphomas, disease progression within 24 months (POD24)
Autor:
Jean-Christophe Navellou, Ana Berceanu, Laurence Millon, Anne-Sophie Brunel, Quentin Lepiller, Annie Brion, Anne-Pauline Bellanger
Publikováno v:
Infectious Diseases Now
Infectious Diseases Now, Elsevier, 2021, ⟨10.1016/j.idnow.2021.01.010⟩
Infectious Diseases Now, Elsevier, 2021, ⟨10.1016/j.idnow.2021.01.010⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53acf5ca1672db200c39cae8596d59d9
https://hal.archives-ouvertes.fr/hal-03315380
https://hal.archives-ouvertes.fr/hal-03315380
Publikováno v:
JCO oncology practice. 16(12)
Autor:
Jean Laganier, Valérie Ducasse, Fabien Martinez, Christophe Segouin, P. Troude, Isabel Nieto, Annie Brion, Raphaël Goudinoux, Rémy Nizard
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Whereas handover of pertinent information between hospital and primary care is necessary to ensure continuity of care and patient safety, both quality of content and timeliness of discharge s
Whereas handover of pertinent information between hospital and primary care is necessary to ensure continuity of care and patient safety, both quality of content and timeliness of discharge s
Autor:
Phi Linh Nguyen-Thi, Loic Ysebaert, Marie C. Béné, Jehan Dupuis, Daniel Re, Godelieve Meunier, Pierre Feugier, Richard Lemal, Thérèse Aurran, Stéphane Leprêtre, Annie Brion, Bruno Cazin, Cécile Tomowiak, Guillaume Cartron, Anne Sophie Michallet, Véronique Leblond, Florence Cymbalista, Anne Quinquenel, Marie Sarah Dilhuydy, Pierre Morel
Publikováno v:
Hematological Oncology. 35:671-678
The mean age at diagnosis of chronic lymphocytic leukemia (CLL) is 72 years, with 22.8% of patients being older than 80 years. However, the elderly are underrepresented in clinical studies of CLL. We performed a retrospective study of CLL patients ag
Autor:
Romain Guieze, Anne Calleja, Loic Ysebaert, Anne-Sophie Michallet, Emmanuelle Ferrant, Aline Clavert, Fontanet Bijou, Anne Quinquenel, Annie Brion, Kamel Laribi
Publikováno v:
61st Annual Meeting and Exposition of the American Society of Hematology
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.1741, 2019, Blood
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.1741, 2019, Blood
Ibrutinib has revolutionized the management of RR CLL in the past 5 years, improving overall survival (OS) over standard chemo-immunotherapies (CIT) in the registration trials HELIOS and RESONATE. Recently, based on these two studies, a score has bee
Autor:
Anne Quinquenel, Caroline Protin, Caroline Dartigeas, Jehan Dupuis, Véronique Leblond, Sophie Godet, Annie Brion, Loic Ysebaert, Jean-Noël Bastie, David Ghez, Sophie de Guibert, Charles Herbaux, Alain Delmer
Publikováno v:
American journal of hematology. 93(2)
Autor:
Romain Guieze, Thérèse Aurran-Schleinitz, Cécile Tomowiak, Jean-Marc Zini, Florence Cymbalista, Marie-Sarah Dilhuydy, Stéphane Leprêtre, Annie Brion, Anne-Sophie Michallet, Véronique Leblond, Pierre Feugier, Alain Delmer, Loic Ysebaert, Bruno Cazin, Luc-Matthieu Fornecker
Publikováno v:
American Journal of Hematology. 90:511-514
The optimal management of patients with relapsed chronic lymphocytic leukemia (CLL) is dictated by the type of prior therapy, duration of prior response, presence of genomic aberrations, age, and comorbidities. The patterns of relapses and the clinic